News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,240 Results
Type
Article (49901)
Company Profile (278)
Press Release (687061)
Multimedia
Podcasts (63)
Webinars (12)
Section
Business (212362)
Career Advice (2099)
Deals (36540)
Drug Delivery (104)
Drug Development (83653)
Employer Resources (173)
FDA (16993)
Job Trends (15724)
News (359391)
Policy (34708)
Tag
Academia (2783)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51634)
ALS (96)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (134)
Approvals (16993)
Artificial intelligence (280)
Autoimmune disease (23)
Automation (16)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (297)
Cancer (2349)
Cardiovascular disease (191)
Career advice (1763)
Career pathing (31)
CAR-T (155)
Cell therapy (436)
Cervical cancer (22)
Clinical research (67982)
Collaboration (875)
Company closure (1)
Compensation (554)
Complete response letters (21)
COVID-19 (2719)
CRISPR (43)
C-suite (261)
Cystic fibrosis (102)
Data (2300)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (282)
Diagnostics (6588)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88951)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117568)
Executive appointments (752)
FDA (18358)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (114)
Generative AI (25)
Gene therapy (316)
GLP-1 (766)
Government (4691)
Grass and pollen (4)
Guidances (108)
Healthcare (19908)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2870)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (320)
IPO (16886)
IRA (41)
Job creations (4047)
Job search strategy (1502)
Kidney cancer (10)
Labor market (40)
Layoffs (489)
Leadership (18)
Legal (8466)
Liver cancer (80)
Lung cancer (331)
Lymphoma (156)
Machine learning (8)
Management (58)
Manufacturing (326)
MASH (73)
Medical device (14389)
Medtech (14394)
Mergers & acquisitions (20221)
Metabolic disorders (735)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (2012)
NextGen: Class of 2025 (6913)
Non-profit (4741)
Now hiring (40)
Obesity (393)
Opinion (218)
Ovarian cancer (78)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (242)
Patient recruitment (117)
Peanut (48)
People (60200)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21151)
Phase II (29874)
Phase III (22317)
Pipeline (1289)
Policy (146)
Postmarket research (2741)
Preclinical (9037)
Press Release (67)
Prostate cancer (110)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (393)
Real estate (6305)
Recruiting (65)
Regulatory (23744)
Reports (46)
Research institute (2483)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (131)
Series B (90)
Service/supplier (13)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3835)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (45)
The Weekly (33)
Vaccines (735)
Venture capitalists (42)
Weight loss (264)
Women's health (38)
Worklife (16)
Date
Today (296)
Last 7 days (877)
Last 30 days (2954)
Last 365 days (33424)
2025 (11560)
2024 (36113)
2023 (41151)
2022 (52384)
2021 (57102)
2020 (55916)
2019 (48800)
2018 (36946)
2017 (33750)
2016 (33575)
2015 (39617)
2014 (33328)
2013 (28568)
2012 (30857)
2011 (31558)
2010 (29926)
Location
Africa (795)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (41052)
Australia (6764)
California (6330)
Canada (2053)
China (550)
Colorado (281)
Connecticut (292)
Delaware (157)
Europe (89008)
Florida (937)
Georgia (216)
Idaho (61)
Illinois (586)
India (26)
Indiana (320)
Iowa (11)
Japan (170)
Kansas (107)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (949)
Massachusetts (4773)
Michigan (230)
Minnesota (411)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (68)
New Jersey (1794)
New Mexico (29)
New York (1799)
North Carolina (1050)
North Dakota (8)
Northern California (2768)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1414)
Puerto Rico (12)
Rhode Island (35)
South America (1188)
South Carolina (26)
South Dakota (1)
Southern California (2375)
Tennessee (105)
Texas (947)
United States (24099)
Utah (189)
Virginia (155)
Washington D.C. (68)
Washington State (578)
West Virginia (3)
Wisconsin (58)
737,240 Results for "fuse medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fuse Oncology Establishes Clinical Liaison Council
March 10, 2025
·
2 min read
Lone Star Bio
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report on Form 10-Q for the quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”).
August 15, 2023
·
10 min read
Press Releases
Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC
February 26, 2025
·
7 min read
Lone Star Bio
Fuse Medical, Inc. Fiscal Year 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (“SEC”) on April 14, 2023.
April 18, 2023
·
11 min read
Business
Fuse Oncology Announces Strategic Collaboration with Radiation Oncology Leader
Fuse Oncology (Fuse), a leading innovator in cutting-edge radiation oncology solutions, announced today a strategic collaboration with the University of Michigan, a recognized leader in radiation oncology.
December 14, 2023
·
2 min read
Business
Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission (“SEC”) on November 14, 2022.
November 15, 2022
·
11 min read
Bio NC
Fuse Oncology Unveils FuseDocs: Newest RadOnc Solution for Streamlining Clinical Documentation for Radiation Oncologists
Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their latest pioneering product, FuseDocs, today.
September 29, 2023
·
3 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
Press Releases
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
April 29, 2025
·
2 min read
1 of 73,724
Next
